期刊文献+

地高辛血清浓度临床相关因素研究 被引量:12

Study on Clinical Influencing Factors of Serum Concentration of Digoxin
原文传递
导出
摘要 目的:通过对地高辛血清浓度(SDC)监测结果及临床相关因素进行分析,为临床医师合理用药提供参考。方法:收集137例患者的病案资料数据,采用统计学方法进行相关分析及多元回归分析,研究各影响因素与SDC之间的关系。结果:剂量、身高、体质量、去脂体质量、体表面积、肌酐清除率、血清肌酐与SDC显著相关(P<0.05)。门诊慢性心力衰竭患者地高辛日剂量宜≤0.125mg,SDC最好控制在0.5~0.9ng.mL-1之内;当肾小球滤过率(GFR)<50mL.min-1.1.73m-2时,病死率随着GFR的升高显著增加。结论:地高辛剂量、体表面积、血清肌酐、肌酐清除率能显著影响SDC。临床医师应结合SDC监测结果,用低剂量达到有效低浓度,能显著降低心力衰竭患者的病死率、再住院率和中毒发生率。 OBJECTIVE:To analyze clinical influencing factors and monitoring results of serum concentration of digoxin (SDC) to provide reference for rational use of drug. METHODS: 137 medical records were collected and analyzed statistically with multiple regression analysis in order to study the relationship of SDC with influencing factors. RESULTS: SDC was significantly affected by dosage, height, body weight, free fat body weight, body surface area, creatinining clearance rate, serum creatinine (P0.05). The daily dose of digoxin in outpatients with chronic heart failure should be below 0.125 mg and SDC should be kept within 0.5~0.9 ng·mL-1. When glomerular filtration rate (GFR) was below 50 mL·min-1·1.73 m-2, mortality increased sharply along with increase of GFR. CONCLUSION: Effect of digoxin on SDC represents as following respects, such as dose, body surface area, creatinine clearance rate and serum creatinine. Clinicians should achieved effective low serum concentration with low dose of digoxin combining with SDC monitoring results to reduce mortality, re-hospitalization rate and poisoning incidence in patients with heart failure.
出处 《中国药房》 CAS CSCD 北大核心 2010年第26期2432-2435,共4页 China Pharmacy
关键词 地高辛 血清浓度 影响因素 统计分析 治疗药物监测 Digoxin Serum concentration Influencing factors Statistical analysis Therapeutic drug monitoring
  • 相关文献

参考文献15

  • 1Chekman IS.Pharmacotherapy of patients with chronic heart failure. Analysis of multieenter international studies [J]. Lik Sprava,2008(1-2 ) :60.
  • 2Gelow JM, Fang JC. Update in the approach to and management of heart failure[J]. South Med J, 2006, 99 (12) :1 346.
  • 3Ahmed A, Pitt B, Rahimtoola SH, et al. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial[J]. Int J Cardiol, 2008,123 (2) : 138.
  • 4Ahmed A, Rich MW, Love TE, et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial[J]. Eur Heart J, 2006,27 (2) : 178.
  • 5Adams KF, Patterson JH, Gattis WA, et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis[J]. J Am Coll Cardiol, 2005,46 (3) :497.
  • 6Hoppe UC, Erdmann E. Digitalis in heart failure[J].Z Kardiol,2005,94(5) :307.
  • 7Hussain Z, Swindle J, Hauptman PJ.Digoxin use and digoxin toxicity in the post-DIG trial era[J]. J Card Fail, 2006,12(5) : 343.
  • 8Ahmed A. Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations[J]. J Gerontol A Biol Sci Med Sci, 2007,62(3) : 323.
  • 9李景苏,蔡长春,侯艳宁.地高辛给药方案与血药浓度及临床疗效的关系[J].临床误诊误治,2006,19(1):3-5. 被引量:17
  • 10Shlipak MG, Smith GL, Rathore SS, et al. Digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial[J]. J Am Soc Nephrol, 2004, 15 (8):2 195.

二级参考文献7

  • 1司凯英,王守春,栾杰,高志刚,韩丽萍,肖艳.地高辛治疗窗浓度的再探讨[J].中国药房,2005,16(14):1081-1083. 被引量:12
  • 2陈新谦 金有豫.新编药物学:第14版[M].北京:人民卫生出版社,1998.552.
  • 3陈新谦主编.新编药物学:第14版[M].北京:人民卫生出版社,1998.252.
  • 4Slatton ML,Irani WN, Hall SA,et al. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure in normal sinus rhythm [ J ]. Am J Coll Cardiol, 1997,29:1206.
  • 5Gheorghiade M,Adams KJ, Colucci WS. Digoxin in th management of cardiovascular disorders [ J ]. Circulation, 2004,109:2959-2964.
  • 6Saif SR, Jeptha PC, Yongfei W, et al. Association of serum digoxin concentration and outcomes in patients with heart failure[J]. JAMA,2003,289:871-878.
  • 7王曼丽,关铭华,徐辰,刘芸,王汝龙.不同类型患者地高辛治疗窗的确定[J].中国新药杂志,2000,9(1):36-37. 被引量:9

共引文献19

同被引文献95

引证文献12

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部